| Surrogate endpoints in health technology assessment: an international review of methodological guidelines B Grigore, O Ciani, F Dams, C Federici, S de Groot, M Möllenkamp, ... Pharmacoeconomics 38 (10), 1055-1070, 2020 | 48 | 2020 |
| Differences in health care spending and utilization among older frail adults in high‐income countries: ICCONIC hip fracture persona I Papanicolas, JF Figueroa, AJ Schoenfeld, K Riley, O Abiona, M Arvin, ... Health services research 56, 1335-1346, 2021 | 28 | 2021 |
| International comparison of health spending and utilization among people with complex multimorbidity JF Figueroa, I Papanicolas, K Riley, O Abiona, M Arvin, F Atsma, ... Health Services Research 56, 1317-1334, 2021 | 26 | 2021 |
| Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges C Federici, V Reckers-Droog, O Ciani, F Dams, B Grigore, Z Kaló, ... The European Journal of Health Economics 22 (8), 1253-1273, 2021 | 21 | 2021 |
| Improving health care from the bottom up: Factors for the successful implementation of kaizen in acute care hospitals K Shatrov, C Pessina, K Huber, B Thomet, A Gutzeit, CR Blankart PloS one 16 (9), e0257412, 2021 | 21 | 2021 |
| Regulatory and HTA early dialogues in medical devices CR Blankart, F Dams, H Penton, Z Kaló, A Zemplényi, K Shatrov, ... Health Policy 125 (10), 1322-1329, 2021 | 15 | 2021 |
| International comparison of spending and utilization at the end of life for hip fracture patients CR Blankart, K van Gool, I Papanicolas, E Bernal‐Delgado, N Bowden, ... Health Services Research 56, 1370-1382, 2021 | 12 | 2021 |
| Differences in health outcomes for h igh‐need h igh‐cost patients across h igh‐income countries I Papanicolas, K Riley, O Abiona, M Arvin, F Atsma, E Bernal‐Delgado, ... Health services research 56, 1347-1357, 2021 | 11 | 2021 |
| A methodology for identifying high‐need, high‐cost patient personas for international comparisons JF Figueroa, KE Horneffer, K Riley, O Abiona, M Arvin, F Atsma, ... Health services research 56, 1302-1316, 2021 | 8 | 2021 |
| After the four-year transition period: Is the European Union's Medical Device Regulation of 2017 likely to achieve its main goals? K Shatrov, CR Blankart Health Policy 126 (12), 1233-1240, 2022 | 6 | 2022 |
| How to pay primary care physicians for SARS-CoV-2 vaccinations: an analysis of 43 EU and OECD countries R Milstein, K Shatrov, LM Schmutz, CR Blankart Health Policy 126 (6), 485-492, 2022 | 6 | 2022 |
| Within and across country variations in treatment of patients with heart failure and diabetes Z Or, K Shatrov, A Penneau, W Wodchis, O Abiona, CR Blankart, ... Health services research 56, 1358-1369, 2021 | 6 | 2021 |
| Why the US spends more treating high-need high-cost patients: a comparative study of pricing and utilization of care in six high-income countries L Lorenzoni, A Marino, Z Or, CR Blankart, K Shatrov, W Wodchis, ... Health Policy 128, 55-61, 2023 | 3 | 2023 |
| Exploring the Link between Organizational Change Capacity and Performance in the Medtech Industry in Switzerland K Shatrov, CR Blankart 2019 World Congress on Health Economics, 2019 | | 2019 |
| Organized Session: International Comparison of High-Need, High-Cost Patients: What Can We Learn about Health System Performance? K Shatrov 2019 World Congress on Health Economics, 2019 | | 2019 |
| Evaluation der Impfpromotion und Erhöhung der Impfbereitschaft J Trageser, K Shatrov, T von Stokar, S Hammer, S Fries, S Bogler | | |
| Umfrage bei Kantonen zu direkten pandemiebedingten Gesundheitskosten der Kantone aufgrund der Covid-19-Pandemie J Trageser, K Shatrov, T von Stokar | | |
| Major regulatory shifts as a driver of organizational change in health care: A macro and a micro perspective KD Shatrov Universität Bern, 0 | | |
